a managerial perspective on clinical trials
This is a PDF document titled "A Managerial Perspective on Clinical Trials.pdf" created in September 2025. It provides a comprehensive academic and managerial overview of clinical trials, covering their history, regulatory environment, phases, design considerations, ethical issues, and contemporary challenges. The content is structured as an educational or professional note likely intended for business or medical management audiences, authored by Harvard Business School faculty and affiliates. It includes detailed explanations of clinical trial methodology, management strategies, and global trends, but does not represent a conversation or dialogue.
Questions this document answers
They are regulated by organizations like FDA, EMA, and others that set guidelines and approve drugs.
CROs are organizations that manage parts or all of the trial process.
Stakeholders influence ethical standards, trial design, and access.
The durations vary, with Phase I lasting a few months, Phase II 6 months to 2 years, Phase III 2-5 years, and IV ongoing after approval.
Approval involves reviewing trial data to decide on market authorization.